SEC Filing Summary for Monte Rosa Therapeutics, Inc. - Form 4 Filing

This filing details stock transactions by Townson Sharon, Chief Scientific Officer of Monte Rosa Therapeutics, Inc. On June 17, 2026, Sharon acquired 3,000 shares of Common Stock at $6.14 per share and disposed of 3,000 shares of Common Stock at $19.00 per share. Additionally, an option to buy 3,000 shares of Common Stock was exercised. These transactions were executed under a Rule 10b5-1 trading plan. Following these transactions, Sharon directly owns 67,845 shares of Common Stock and has options for 206,290 shares. The option exercised was fully vested and exercisable.